At a glance

ClinicalIndex Comparison Record

N/ACompleted

Drug / intervention

Not specified

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00235768

NCT00235768N/ACompleted

Compare CT.gov

Neurotoxicity of Ecstasy: Causality, Course and Clinical Relevance

UMC Utrecht·observational·Posted Oct 10, 2005·Updated Oct 10, 2005

In Brief

An observational study for Ecstasy (Drug) and 2 related conditions. Completed, across 3 sites.

Detailed Summary

The purpose of this study is to investigate the possible neurotoxic effects of the party-drug Ecstasy (MDMA)on brain and brain function in humans. Main research questions concern the causality, course and clinical relevance of the neurotoxicity of ecstasy

Study Details

Study Typeobservational

Allocation--

Masking--

Primary Purpose--

ConditionsEcstasy (Drug), N-Methyl-3,4-Methylenedioxymethamphetamine, Psychopathology

CountriesNetherlands

CollaboratorsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University of Amsterdam, Bonger Institute of Criminology, Erasmus Medical Center

Timeline

N/ACompletedFinished

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartApr 2002

Study CompletionJul 2005

First PostedOct 2005

TodayJul 2026

First PostedOct 10, 2005

Enrollment StartApr 1, 2002

Study CompletionJul 1, 2005

TodayJul 2, 2026

Posted 20.7 years ago